Department of Pathology and Clinical Laboratories, University of Michigan-Michigan Medicine, Ann Arbor, MI.
Adv Anat Pathol. 2022 Nov 1;29(6):373-379. doi: 10.1097/PAP.0000000000000356. Epub 2022 Jul 19.
Adrenal gland lesions are present in 1% to 5% of patients and are most commonly identified incidentally on abdominal imaging. Fine needle aspiration (FNA) cytology plays an important role in the initial workup of adrenal gland nodules, especially in patients with a known history of malignancy. The most common reason for adrenal gland FNA is to differentiate benign adrenal lesions, such as adrenal cortical adenoma, from metastatic malignancy. However, there is a significant cytomorphologic overlap between primary and metastatic adrenal neoplasms. This review focuses on the current state of adrenal gland FNA cytology, with an emphasis on distinguishing adrenocortical adenoma from carcinoma and adrenal cortical neoplasms from metastatic malignancies. The role of immunohistochemistry in specifically diagnosing adrenal neoplasms is discussed. Proposed diagnostic classification systems for adrenal gland FNA cytology are also described.
肾上腺病变在 1%至 5%的患者中存在,最常在腹部影像学检查中偶然发现。细针抽吸(FNA)细胞学在肾上腺结节的初始检查中起着重要作用,特别是在已知患有恶性肿瘤病史的患者中。进行肾上腺 FNA 的最常见原因是区分良性肾上腺病变,如肾上腺皮质腺瘤,与转移性恶性肿瘤。然而,原发性和转移性肾上腺肿瘤之间存在明显的细胞形态学重叠。本综述重点介绍了当前的肾上腺 FNA 细胞学状态,特别强调了区分肾上腺皮质腺瘤与癌以及肾上腺皮质肿瘤与转移性恶性肿瘤。还讨论了免疫组织化学在专门诊断肾上腺肿瘤中的作用。还描述了用于肾上腺 FNA 细胞学的拟议诊断分类系统。